 | • レポートコード：GIR201112545 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、注射型薬物送達製剤の世界市場を調査対象にし、注射型薬物送達製剤の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（従来型ドラッグデリバリー製剤、新規ドラッグデリバリー製剤、長時間作用型製剤）、用途別分析（自己免疫疾患、ホルモン障害、腫瘍学、希少疾患、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Becton, Dickinson and Company (US)、Eli Lilly and Company (US)、Pfizer, Inc. (US)、Baxter International Inc. (US)、Teva Pharmaceutical Industries Ltd. (Israel)、Gerresheimer AG (Germany)、Sandoz (Germany)、Schott AG (Germany) ・メーカー別販売量、売上、市場シェア ・注射型薬物送達製剤の地域別市場分析 ・注射型薬物送達製剤の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・注射型薬物送達製剤のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・注射型薬物送達製剤のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・注射型薬物送達製剤の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・注射型薬物送達製剤の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・注射型薬物送達製剤の種類別市場規模2015-2020：従来型ドラッグデリバリー製剤、新規ドラッグデリバリー製剤、長時間作用型製剤 ・注射型薬物送達製剤の用途別市場規模2015-2020：自己免疫疾患、ホルモン障害、腫瘍学、希少疾患、その他 ・注射型薬物送達製剤の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Injectable Drug Delivery Formulation market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Injectable Drug Delivery Formulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Injectable Drug Delivery Formulation market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Injectable Drug Delivery Formulation market has been segmented into
Conventional Drug Delivery Formulations
Novel Drug Delivery Formulations
Long-acting Formulations
By Application, Injectable Drug Delivery Formulation has been segmented into:
Autoimmune Diseases
Hormonal Disorders
Oncology
Orphan Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Injectable Drug Delivery Formulation market presented in the report. This section sheds light on the sales growth of different regional and country-level Injectable Drug Delivery Formulation markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Injectable Drug Delivery Formulation market.
The report offers in-depth assessment of the growth and other aspects of the Injectable Drug Delivery Formulation market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Injectable Drug Delivery Formulation Market Share Analysis
Injectable Drug Delivery Formulation competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Injectable Drug Delivery Formulation sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Injectable Drug Delivery Formulation sales, revenue and market share for each player covered in this report.
The major players covered in Injectable Drug Delivery Formulation are:
Becton, Dickinson and Company (US)
Eli Lilly and Company (US)
Pfizer, Inc. (US)
Baxter International Inc. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Gerresheimer AG (Germany)
Sandoz (Germany)
Schott AG (Germany)
Among other players domestic and global, Injectable Drug Delivery Formulation market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Injectable Drug Delivery Formulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Injectable Drug Delivery Formulation, with price, sales, revenue and global market share of Injectable Drug Delivery Formulation in 2018 and 2019.
Chapter 3, the Injectable Drug Delivery Formulation competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Injectable Drug Delivery Formulation breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Injectable Drug Delivery Formulation market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Injectable Drug Delivery Formulation sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Injectable Drug Delivery Formulation Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Injectable Drug Delivery Formulation Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Conventional Drug Delivery Formulations
1.2.3 Novel Drug Delivery Formulations
1.2.4 Long-acting Formulations
1.3 Market Analysis by Application
1.3.1 Overview: Global Injectable Drug Delivery Formulation Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Autoimmune Diseases
1.3.3 Hormonal Disorders
1.3.4 Oncology
1.3.5 Orphan Diseases
1.3.6 Others
1.4 Overview of Global Injectable Drug Delivery Formulation Market
1.4.1 Global Injectable Drug Delivery Formulation Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Becton, Dickinson and Company (US)
2.1.1 Becton, Dickinson and Company (US) Details
2.1.2 Becton, Dickinson and Company (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Becton, Dickinson and Company (US) SWOT Analysis
2.1.4 Becton, Dickinson and Company (US) Product and Services
2.1.5 Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Eli Lilly and Company (US)
2.2.1 Eli Lilly and Company (US) Details
2.2.2 Eli Lilly and Company (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Eli Lilly and Company (US) SWOT Analysis
2.2.4 Eli Lilly and Company (US) Product and Services
2.2.5 Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer, Inc. (US)
2.3.1 Pfizer, Inc. (US) Details
2.3.2 Pfizer, Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer, Inc. (US) SWOT Analysis
2.3.4 Pfizer, Inc. (US) Product and Services
2.3.5 Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Baxter International Inc. (US)
2.4.1 Baxter International Inc. (US) Details
2.4.2 Baxter International Inc. (US) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Baxter International Inc. (US) SWOT Analysis
2.4.4 Baxter International Inc. (US) Product and Services
2.4.5 Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical Industries Ltd. (Israel)
2.5.1 Teva Pharmaceutical Industries Ltd. (Israel) Details
2.5.2 Teva Pharmaceutical Industries Ltd. (Israel) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva Pharmaceutical Industries Ltd. (Israel) SWOT Analysis
2.5.4 Teva Pharmaceutical Industries Ltd. (Israel) Product and Services
2.5.5 Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Gerresheimer AG (Germany)
2.6.1 Gerresheimer AG (Germany) Details
2.6.2 Gerresheimer AG (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Gerresheimer AG (Germany) SWOT Analysis
2.6.4 Gerresheimer AG (Germany) Product and Services
2.6.5 Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sandoz (Germany)
2.7.1 Sandoz (Germany) Details
2.7.2 Sandoz (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sandoz (Germany) SWOT Analysis
2.7.4 Sandoz (Germany) Product and Services
2.7.5 Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Schott AG (Germany)
2.8.1 Schott AG (Germany) Details
2.8.2 Schott AG (Germany) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Schott AG (Germany) SWOT Analysis
2.8.4 Schott AG (Germany) Product and Services
2.8.5 Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Injectable Drug Delivery Formulation Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Injectable Drug Delivery Formulation Manufacturer Market Share in 2019
3.3.2 Top 6 Injectable Drug Delivery Formulation Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Injectable Drug Delivery Formulation Sales, Revenue and Market Share by Regions
4.1.1 Global Injectable Drug Delivery Formulation Sales and Market Share by Regions (2015-2020)
4.1.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Regions (2015-2020)
4.2 North America Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
4.3 Europe Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
4.5 South America Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Injectable Drug Delivery Formulation Sales, Revenue and Market Share by Country
5.1.1 North America Injectable Drug Delivery Formulation Sales and Market Share by Country (2015-2020)
5.1.2 North America Injectable Drug Delivery Formulation Revenue and Market Share by Country (2015-2020)
5.2 United States Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
5.3 Canada Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
5.4 Mexico Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Injectable Drug Delivery Formulation Sales, Revenue and Market Share by Country
6.1.1 Europe Injectable Drug Delivery Formulation Sales and Market Share by Country (2015-2020)
6.1.2 Europe Injectable Drug Delivery Formulation Revenue and Market Share by Country (2015-2020)
6.2 Germany Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
6.3 UK Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
6.4 France Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
6.5 Russia Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
6.6 Italy Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Injectable Drug Delivery Formulation Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Injectable Drug Delivery Formulation Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Injectable Drug Delivery Formulation Revenue and Market Share by Regions (2015-2020)
7.2 China Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
7.3 Japan Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
7.4 Korea Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
7.5 India Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
7.7 Australia Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Injectable Drug Delivery Formulation Sales, Revenue and Market Share by Country
8.1.1 South America Injectable Drug Delivery Formulation Sales and Market Share by Country (2015-2020)
8.1.2 South America Injectable Drug Delivery Formulation Revenue and Market Share by Country (2015-2020)
8.2 Brazil Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
8.3 Argentina Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Injectable Drug Delivery Formulation Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Injectable Drug Delivery Formulation Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Injectable Drug Delivery Formulation Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
9.3 Turkey Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
9.4 Egypt Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
9.5 South Africa Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Injectable Drug Delivery Formulation Sales and Market Share by Type (2015-2020)
10.2 Global Injectable Drug Delivery Formulation Revenue and Market Share by Type (2015-2020)
10.3 Global Injectable Drug Delivery Formulation Price by Type (2015-2020)
11 Global Injectable Drug Delivery Formulation Market Segment by Application
11.1 Global Injectable Drug Delivery Formulation Sales Market Share by Application (2015-2020)
11.2 Global Injectable Drug Delivery Formulation Revenue Market Share by Application (2015-2020)
11.3 Global Injectable Drug Delivery Formulation Price by Application (2015-2020)
12 Market Forecast
12.1 Global Injectable Drug Delivery Formulation Sales, Revenue and Growth Rate (2021-2025)
12.2 Injectable Drug Delivery Formulation Market Forecast by Regions (2021-2025)
12.2.1 North America Injectable Drug Delivery Formulation Market Forecast (2021-2025)
12.2.2 Europe Injectable Drug Delivery Formulation Market Forecast (2021-2025)
12.2.3 Asia-Pacific Injectable Drug Delivery Formulation Market Forecast (2021-2025)
12.2.4 South America Injectable Drug Delivery Formulation Market Forecast (2021-2025)
12.2.5 Middle East & Africa Injectable Drug Delivery Formulation Market Forecast (2021-2025)
12.3 Injectable Drug Delivery Formulation Market Forecast by Type (2021-2025)
12.3.1 Global Injectable Drug Delivery Formulation Sales Forecast by Type (2021-2025)
12.3.2 Global Injectable Drug Delivery Formulation Market Share Forecast by Type (2021-2025)
12.4 Injectable Drug Delivery Formulation Market Forecast by Application (2021-2025)
12.4.1 Global Injectable Drug Delivery Formulation Sales Forecast by Application (2021-2025)
12.4.2 Global Injectable Drug Delivery Formulation Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Injectable Drug Delivery Formulation Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Injectable Drug Delivery Formulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Injectable Drug Delivery Formulation Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Becton, Dickinson and Company (US) Basic Information, Manufacturing Base and Competitors
Table 8. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Major Business
Table 9. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Total Revenue (USD Million) (2018-2019)
Table 10. Becton, Dickinson and Company (US) SWOT Analysis
Table 11. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Product and Services
Table 12. Becton, Dickinson and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Eli Lilly and Company (US) Basic Information, Manufacturing Base and Competitors
Table 14. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Major Business
Table 15. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Total Revenue (USD Million) (2018-2019)
Table 16. Eli Lilly and Company (US) SWOT Analysis
Table 17. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Product and Services
Table 18. Eli Lilly and Company (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer, Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Major Business
Table 21. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Total Revenue (USD Million) (2018-2019)
Table 22. Pfizer, Inc. (US) SWOT Analysis
Table 23. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Product and Services
Table 24. Pfizer, Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Baxter International Inc. (US) Basic Information, Manufacturing Base and Competitors
Table 26. Baxter International Inc. (US) Injectable Drug Delivery Formulation Major Business
Table 27. Baxter International Inc. (US) Injectable Drug Delivery Formulation Total Revenue (USD Million) (2018-2019)
Table 28. Baxter International Inc. (US) SWOT Analysis
Table 29. Baxter International Inc. (US) Injectable Drug Delivery Formulation Product and Services
Table 30. Baxter International Inc. (US) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Pharmaceutical Industries Ltd. (Israel) Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Major Business
Table 33. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Total Revenue (USD Million) (2018-2019)
Table 34. Teva Pharmaceutical Industries Ltd. (Israel) SWOT Analysis
Table 35. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Product and Services
Table 36. Teva Pharmaceutical Industries Ltd. (Israel) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Gerresheimer AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 38. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Major Business
Table 39. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Total Revenue (USD Million) (2018-2019)
Table 40. Gerresheimer AG (Germany) SWOT Analysis
Table 41. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Product and Services
Table 42. Gerresheimer AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Sandoz (Germany) Basic Information, Manufacturing Base and Competitors
Table 44. Sandoz (Germany) Injectable Drug Delivery Formulation Major Business
Table 45. Sandoz (Germany) Injectable Drug Delivery Formulation Total Revenue (USD Million) (2018-2019)
Table 46. Sandoz (Germany) SWOT Analysis
Table 47. Sandoz (Germany) Injectable Drug Delivery Formulation Product and Services
Table 48. Sandoz (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Schott AG (Germany) Basic Information, Manufacturing Base and Competitors
Table 50. Schott AG (Germany) Injectable Drug Delivery Formulation Major Business
Table 51. Schott AG (Germany) Injectable Drug Delivery Formulation Total Revenue (USD Million) (2018-2019)
Table 52. Schott AG (Germany) SWOT Analysis
Table 53. Schott AG (Germany) Injectable Drug Delivery Formulation Product and Services
Table 54. Schott AG (Germany) Injectable Drug Delivery Formulation Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Injectable Drug Delivery Formulation Sales by Manufacturer (2018-2019) (K Pcs)
Table 56. Global Injectable Drug Delivery Formulation Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Injectable Drug Delivery Formulation Sales by Regions (2015-2020) (K Pcs)
Table 58. Global Injectable Drug Delivery Formulation Sales Market Share by Regions (2015-2020)
Table 59. Global Injectable Drug Delivery Formulation Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Injectable Drug Delivery Formulation Sales by Countries (2015-2020) (K Pcs)
Table 61. North America Injectable Drug Delivery Formulation Sales Market Share by Countries (2015-2020)
Table 62. North America Injectable Drug Delivery Formulation Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Injectable Drug Delivery Formulation Revenue Market Share by Countries (2015-2020)
Table 64. Europe Injectable Drug Delivery Formulation Sales by Countries (2015-2020) (K Pcs)
Table 65. Europe Injectable Drug Delivery Formulation Sales Market Share by Countries (2015-2020)
Table 66. Europe Injectable Drug Delivery Formulation Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Injectable Drug Delivery Formulation Sales by Regions (2015-2020) (K Pcs)
Table 68. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Injectable Drug Delivery Formulation Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Injectable Drug Delivery Formulation Sales by Countries (2015-2020) (K Pcs)
Table 71. South America Injectable Drug Delivery Formulation Sales Market Share by Countries (2015-2020)
Table 72. South America Injectable Drug Delivery Formulation Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Injectable Drug Delivery Formulation Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Injectable Drug Delivery Formulation Sales by Countries (2015-2020) (K Pcs)
Table 75. Middle East & Africa Injectable Drug Delivery Formulation Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Injectable Drug Delivery Formulation Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Injectable Drug Delivery Formulation Revenue Market Share by Countries (2015-2020)
Table 78. Global Injectable Drug Delivery Formulation Sales by Type (2015-2020) (K Pcs)
Table 79. Global Injectable Drug Delivery Formulation Sales Share by Type (2015-2020)
Table 80. Global Injectable Drug Delivery Formulation Revenue by Type (2015-2020) (USD Million)
Table 81. Global Injectable Drug Delivery Formulation Revenue Share by Type (2015-2020)
Table 82. Global Injectable Drug Delivery Formulation Sales by Application (2015-2020) (K Pcs)
Table 83. Global Injectable Drug Delivery Formulation Sales Share by Application (2015-2020)
Table 84. Global Injectable Drug Delivery Formulation Sales Forecast by Regions (2021-2025) (K Pcs)
Table 85. Global Injectable Drug Delivery Formulation Market Share Forecast by Regions (2021-2025)
Table 86. Global Injectable Drug Delivery Formulation Sales Forecast by Type (2021-2025) (K Pcs)
Table 87. Global Injectable Drug Delivery Formulation Market Share Forecast by Type (2021-2025)
Table 88. Global Injectable Drug Delivery Formulation Sales Forecast by Application (2021-2025)
Table 89. Global Injectable Drug Delivery Formulation Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Injectable Drug Delivery Formulation Picture
Figure 2. Global Sales Market Share of Injectable Drug Delivery Formulation by Type in 2019
Figure 3. Conventional Drug Delivery Formulations Picture
Figure 4. Novel Drug Delivery Formulations Picture
Figure 5. Long-acting Formulations Picture
Figure 6. Injectable Drug Delivery Formulation Sales Market Share by Application in 2018
Figure 7. Autoimmune Diseases Picture
Figure 8. Hormonal Disorders Picture
Figure 9. Oncology Picture
Figure 10. Orphan Diseases Picture
Figure 11. Others Picture
Figure 12. Global Injectable Drug Delivery Formulation Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Injectable Drug Delivery Formulation Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Injectable Drug Delivery Formulation Sales Market Share by Manufacturer in 2019
Figure 33. Global Injectable Drug Delivery Formulation Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Injectable Drug Delivery Formulation Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Injectable Drug Delivery Formulation Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Injectable Drug Delivery Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Injectable Drug Delivery Formulation Revenue Market Share by Regions (2015-2020)
Figure 40. Global Injectable Drug Delivery Formulation Revenue Market Share by Regions in 2018
Figure 41. North America Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
Figure 42. Europe Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
Figure 44. South America Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020)
Figure 46. North America Injectable Drug Delivery Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Injectable Drug Delivery Formulation Sales Market Share by Countries (2015-2020)
Figure 48. North America Injectable Drug Delivery Formulation Sales Market Share by Countries in 2018
Figure 49. North America Injectable Drug Delivery Formulation Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Injectable Drug Delivery Formulation Revenue Market Share by Countries in 2018
Figure 51. United States Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Injectable Drug Delivery Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Injectable Drug Delivery Formulation Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Injectable Drug Delivery Formulation Revenue Market Share by Countries in 2019
Figure 57. Germany Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Injectable Drug Delivery Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Injectable Drug Delivery Formulation Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Injectable Drug Delivery Formulation Revenue Market Share by Regions 2019
Figure 65. China Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Injectable Drug Delivery Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Injectable Drug Delivery Formulation Sales Market Share by Countries in 2019
Figure 72. South America Injectable Drug Delivery Formulation Revenue Market Share by Countries in 2019
Figure 73. Brazil Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Injectable Drug Delivery Formulation Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Injectable Drug Delivery Formulation Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Injectable Drug Delivery Formulation Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Injectable Drug Delivery Formulation Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Injectable Drug Delivery Formulation Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Injectable Drug Delivery Formulation Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Injectable Drug Delivery Formulation Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Injectable Drug Delivery Formulation Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Injectable Drug Delivery Formulation Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Injectable Drug Delivery Formulation Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Injectable Drug Delivery Formulation Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
鼻腔内薬物送達デバイスの世界市場 2020年 Market Overview The Intranasal Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…- バイオ医薬品ドラッグデリバリーデバイスの世界市場 2020年 Market Overview The global Biopharmaceutical Drug Delivery Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bioph…
- スマートドラッグデリバリードローンの世界市場 2020年 Market Overview The global Smart Drug Delivery Drones market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Smart Drug Deliver…
- 埋め込み型無針薬物デリバリーの世界市場 2020年 Market Overview The global Implantable and Needle-Free Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Imp…
- 経皮・経粘膜ドラッグデリバリーの世界市場 2020年 Market Overview The global Transdermal and Transmucosal Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tr…